Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Wolber

Showing results (171-180 of 213) with videos related to

Pageof 22
Sort By:
Drug Testing and Analysis|November 20, 2025
Further Insights Into the Metabolism of LGD-4033 in Human Urine. Part 2. A New Minor Metabolite With Antagonistic Activity on the Androgen Receptor Can Indicate Recent Substance IntakeYiannis S Angelis, Panagiotis Sakellariou, Annekathrin M Keiler, et al.
Journal of Medicinal Chemistry|January 13, 2018
Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C ProteasesRobert Schulz, Amira Atef, Daniel Becker, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
An Ongoing Search for Multitarget Ligands as Potential Agents for Diabetes Mellitus and Its Long-Term Complications: New Insights into (5-Arylidene-4-oxothiazolidin-3-yl)alkanoic Acid DerivativesRosanna Maccari, Rosaria Ottanà, Valerij Talagayev, et al.
Applied Biochemistry and Biotechnology|October 26, 2022
Exploring the Chemical Space of Proluciferins as Probe Substrates for Human Cytochrome P450 EnzymesJie Zhao, Xue Zhang, Yueyin Wang, et al.
Journal of Chemical Information and Modeling|July 22, 2008
Discovery of novel cathepsin S inhibitors by pharmacophore-based virtual high-throughput screeningPatrick Markt, Caroline McGoohan, Brian Walker, et al.
European Journal of Medicinal Chemistry|March 19, 2023
Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: Discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitorsRosanna Maccari, Gerhard Wolber, Massimo Genovese, et al.
Planta Medica|November 6, 2014
Isomeric C12-alkamides from the roots of Echinacea purpurea improve basal and insulin-dependent glucose uptake in 3T3-L1 adipocytesDorota Kotowska, Rime B El-Houri, Kamil Borkowski, et al.
Chemmedchem|January 3, 2013
Butyltin(IV) benzoates: inhibition of thioredoxin reductase, tumor cell growth inhibition, and interactions with proteinsKely Navakoski de Oliveira, Vincent Andermark, Susanne von Grafenstein, et al.
Molecules (Basel, Switzerland)|January 13, 2021
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1BRosaria Ottanà, Paolo Paoli, Mario Cappiello, et al.
The Journal of Biological Chemistry|June 15, 2016
Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled ReceptorAndreas Bock, Marcel Bermudez, Fabian Krebs, et al.
Pageof 22

Showing results (171-180 of 213) with videos related to

Sort By:
Pageof 22
Drug Testing and Analysis|November 20, 2025
Further Insights Into the Metabolism of LGD-4033 in Human Urine. Part 2. A New Minor Metabolite With Antagonistic Activity on the Androgen Receptor Can Indicate Recent Substance IntakeYiannis S Angelis, Panagiotis Sakellariou, Annekathrin M Keiler, et al.
Journal of Medicinal Chemistry|January 13, 2018
Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C ProteasesRobert Schulz, Amira Atef, Daniel Becker, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
An Ongoing Search for Multitarget Ligands as Potential Agents for Diabetes Mellitus and Its Long-Term Complications: New Insights into (5-Arylidene-4-oxothiazolidin-3-yl)alkanoic Acid DerivativesRosanna Maccari, Rosaria Ottanà, Valerij Talagayev, et al.
Applied Biochemistry and Biotechnology|October 26, 2022
Exploring the Chemical Space of Proluciferins as Probe Substrates for Human Cytochrome P450 EnzymesJie Zhao, Xue Zhang, Yueyin Wang, et al.
Journal of Chemical Information and Modeling|July 22, 2008
Discovery of novel cathepsin S inhibitors by pharmacophore-based virtual high-throughput screeningPatrick Markt, Caroline McGoohan, Brian Walker, et al.
European Journal of Medicinal Chemistry|March 19, 2023
Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: Discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitorsRosanna Maccari, Gerhard Wolber, Massimo Genovese, et al.
Planta Medica|November 6, 2014
Isomeric C12-alkamides from the roots of Echinacea purpurea improve basal and insulin-dependent glucose uptake in 3T3-L1 adipocytesDorota Kotowska, Rime B El-Houri, Kamil Borkowski, et al.
Chemmedchem|January 3, 2013
Butyltin(IV) benzoates: inhibition of thioredoxin reductase, tumor cell growth inhibition, and interactions with proteinsKely Navakoski de Oliveira, Vincent Andermark, Susanne von Grafenstein, et al.
Molecules (Basel, Switzerland)|January 13, 2021
In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1BRosaria Ottanà, Paolo Paoli, Mario Cappiello, et al.
The Journal of Biological Chemistry|June 15, 2016
Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled ReceptorAndreas Bock, Marcel Bermudez, Fabian Krebs, et al.
Pageof 22